Illumina claims Element has "borrowed heavily" from the design of its sequencing systems and is seeking damages and an injunction in court.
Following a joint statement from the two countries on Monday, stocks of major life sciences tool and diagnostic companies rallied.
Metastatic Prostate Cancer Study Underscores Precision Medicine Potential in Diverse US Veterans
Researchers profiled somatic changes in tumor samples from thousands of US veterans with metastatic prostate cancer, identifying alterations with varied representation by ancestry.
US Appeals Court Sends UC Berkeley, Broad Institute Back to the Mat in CRISPR-Cas9 Patent Dispute
Premium
It is unclear how the decision will eventually affect Editas Medicine and other companies relying on CRISPR-based technologies and products.
MDxHealth Q1 Revenues Leap 22 Percent
The company's tissue-based test volume grew 41 percent while liquid-based test volume rose 9 percent.
Qiagen Acquires NGS Analysis Software Firm Genoox for up to $80M
The acquisition is expected to generate $5 million in sales for Qiagen this year and have a neutral impact on the firm's EPS.
Quanterix Cuts 2025 Guidance Due to Tariffs, Academic Funding, as Q1 Revenues Fall 5 Percent
Premium
The company lowered its 2025 revenue guidance to between $120.0 million and $130.0 million, representing a year-over-year decline of 5 percent to 13 percent.
Bruker to Pay 10x Genomics $68M Under Global Settlement of Patent Disputes
The companies have inked global patent cross license agreements and will withdraw all ongoing lawsuits and administrative proceedings.